A Call for Transparency, Improved Reporting and Interpretation of Trials Using Surrogate Endpoints in Cardiac Electrophysiology

By sjmartinez • March 2, 2025

Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi M, Chung MK, Ellenbogen KA, Taylor RS. A Call for Transparency, Improved Reporting and Interpretation of Trials Using Surrogate Endpoints in Cardiac Electrophysiology. Heart Rhythm. 2025 Feb 26:S1547-5271(25)00209-7. doi: 10.1016/j.hrthm.2025.02.038. Epub ahead of print. PMID: 40021073.

Tags: Biomarker, Cardiology/Epi, Checklist, Clinical Trial, Outcome, Publications, Randomized Controlled Trial, Research design, standards, surrogate endpoint, surrogate marker

Hepatic lipid metabolism is altered in Ubiad1+/- mice of both sexes

Higa R, Pourteymour S, Kolan PS, Dankel SN, Fernø J, Mellgren G, Pan C, Seldin MM, Lusis AJ, Drevon CA, Dalen KT, Norheim FA. Hepatic[...]

Sex-Divergent Blood Pressure Associations With Multiorgan System Metabolic Stress

Kwan AC, Wang M, Ji H, Claggett B, Ouyang D, Trivedi H, Sharma S, Shyy J, Velazquez A, Ebinger JE, Cheng S. Sex-Divergent Blood Pressure[...]

Association of depression and anxiety with coronary artery plaque among asymptomatic adults: The Miami Heart study (MiHeart) at Baptist Health South Florida

Bafna T, Dzaye O, Dardari Z, Cainzos-Achirica M, Blankstein R, Feldman T, Budoff MJ, Fialkow J, Nasir K, Blaha MJ. Association of depression and anxiety[...]